An HLA-linked human gene, Bevi (mapped to 6p21-6pter) regulates baboon endogenous retrovirun infection in human x rodent somatic cell hybrids. A critical feature of Bevi gene action is that hybrid cells infected with baboon endogenous virun (BEV) shows all evidence of retroviral expression (antigens and virus production) following segregation of hum,an chromosome 6. The molecular cloning and chromosomal assignment of BEV proviruses in hybrid cells shows that Bevi is not a preferred integration domain but, rather, acts in trans to regulate retroviral integration or expression at other sites in the human genone.
The specific aims of this proposal are to use molecular biological techniques (1) to investigate the precise genetic function of the Bevi gene; 92) to elucidate viral and cellular target sequences recognized by the Bevi coded protein; and (3) to determine the biochemical properties of the Bevi gene product. These studies will take advantage of a unique bank of genetically characterized somatic cell hybrid clones that differentially express the Bevi gene. DNA constructs derived from a biologically active, molecularly cloned BEV provirus will be used to elucidate Bevi gene function. Since the human genome does not contain BEV DNA, the normal target of Bevi gene action cannot be BEV itself. An attractive hypothesis is that the Bevi gene product regulates other transcriptional units that bear homology to BEV sequences. The use of retroviral DNA constructs to study Bevi function permits assays for an HLA-linked gene product that may hierarchically control the expression of other human genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM035377-01
Application #
3288000
Study Section
Virology Study Section (VR)
Project Start
1985-07-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Lemons, R S; Espinosa 3rd, R; Rebentisch, M et al. (1990) Chromosomal localization of the gene encoding GTPase-activating protein (RASA) to human chromosome 5, bands q13-q15. Genomics 6:383-5
Albain, K S; Le Beau, M M; Ullirsch, R et al. (1990) Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. Genes Chromosomes Cancer 2:53-8
Adams, R H; Lemons, R S; Thangavelu, M et al. (1989) Interstitial deletion of chromosome 5, del(5q), in a newborn with Down syndrome and an unusual hematologic disorder. Am J Hematol 31:273-9
Le Beau, M M; Lemons, R S; Espinosa 3rd, R et al. (1989) Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 73:647-50
Lublin, D M; Liszewski, M K; Post, T W et al. (1988) Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med 168:181-94
Samuels, B L; Larson, R A; Le Beau, M M et al. (1988) Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 2:79-83
Wetsel, R A; Lemons, R S; Le Beau, M M et al. (1988) Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9. Biochemistry 27:1474-82
Le Beau, M M; Lemons, R S; Carrino, J J et al. (1987) Chromosomal localization of the human G-CSF gene to 17q11 proximal to the breakpoint of the t(15;17) in acute promyelocytic leukemia. Leukemia 1:795-9
Pettenati, M J; Le Beau, M M; Lemons, R S et al. (1987) Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders. Proc Natl Acad Sci U S A 84:2970-4
Lublin, D M; Lemons, R S; Le Beau, M M et al. (1987) The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med 165:1731-6